Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Provides Guidance on 2003 Financials, Reports BeadLab Placement

NEW YORK, Jan. 12 (GenomeWeb News) - Illumina released today financial guidance for the fourth quarter and full year 2003, while also announcing the December installation of a BeadLab SNP genotyping platform at the Human Genome Center of the Institute of Medical Science of the University of Tokyo.

 

According to Illumina, with the installation of the BeadLab at the IMSUT, the company's revenues are likely be about $10.5 million for the fourth quarter and $27.8 million for the full year. The company added that it expects to report total cash, including restricted cash, of roughly $45 million as of Dec. 28.

 

Final fourth quarter and year-end financial results will be released on Jan 27, Illumina added.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.